CUSIP: 87911K100
Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
29,948,325
-
Total 13F shares
-
4,593,229
-
Share change
-
+105,448
-
Total reported value
-
$82,470,887
-
Price per share
-
$17.96
-
Number of holders
-
65
-
Value change
-
+$2,418,762
-
Number of buys
-
34
-
Number of sells
-
32
Quarterly Holders Quick Answers
What is CUSIP 87911K100?
CUSIP 87911K100 identifies HQL - abrdn Life Sciences Investors - Common in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2020
-
Previous quarter:
Q1 2020
Recent filing periods for CUSIP 87911K100:
Institutional Holders of abrdn Life Sciences Investors - Common (HQL) as of Q2 2020
As of 30 Jun 2020,
abrdn Life Sciences Investors - Common (HQL) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,593,229 shares.
The largest 10 holders included
NEEDHAM INVESTMENT MANAGEMENT LLC, 1832 Asset Management L.P., MORGAN STANLEY, Matisse Capital, FLAGSHIP HARBOR ADVISORS, LLC, Advisors Asset Management, Inc., COHEN & STEERS, INC., WELLS FARGO & COMPANY/MN, LAZARD ASSET MANAGEMENT LLC, and 1607 Capital Partners, LLC.
This page lists
65
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.